HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Korea Can Serve As “Market Laboratory” For Beauty Firms In Asia

This article was originally published in The Rose Sheet

Executive Summary

U.S.-based brands including Procter & Gamble and L’Oreal are leveraging the wealth and trend-setting influence of residents of South Korean capital Seoul to test new personal care products.

You may also be interested in...



Avon To Exit South Korea and Vietnam, Cut 1,500 Positions Globally

In an effort to realize $400 million in annual cost savings by 2015, Avon plans to eliminate part of its workforce and withdraw from two Asian markets.

Elements Showcase Provides Launch Pad For Indie Scents

Unlike other trade shows where niche brands may be overshadowed by their larger peers, Elements celebrates the small guys. Its most recent installment in January 2012 attracted 110 brands and buyers from Barneys New York, Sephora, QVC and Saks Fifth Avenue, among other retailers, its founders say.

U.S. Trade Partnerships Augur Overseas Opportunities For Cosmetics

The Trans-Pacific Partnership aims to lower trade barriers between the U.S. and eight other nations and may specifically facilitate market access for cosmetics manufacturers. The Personal Care Products Council says a U.S.-introduced cosmetics annex would mandate regulatory alignment among TPP participants in accordance with international standards and best practices.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018242

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel